New FDA Rule Broadens Scope Of Clinical Investigator Bans
A U.S. Food and Drug Administration rule released Friday would disqualify clinical investigators who are ineligible to conduct preapproval studies of one type of FDA-regulated product — like drugs or medical...To view the full article, register now.
Already a subscriber? Click here to view full article